title: What is the best initial treatment in Parkinson's disease?
authors.affiliation: ME SHarp, Division of Movement Disorders, Deparment of Neurology, Columbia University Medical Center New York, NY 10032, USA. Email ms4567@columbia.edu.
authors.forename: M E
authors.initials: ME
authors.lastname: Sharp
authors.forename: P
authors.initials: P
authors.lastname: Mazzoni
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D008996:Monoamine Oxidase Inhibitors; D007980:Levodopa